Replies to post #31558 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

So Q1 revs of $600K, Q2 revs of $2M and Q3 revs of $1.2M for a total of $3.8M so far.

Q1: $600K
Q2: $2M
Q3: $1.2M
Q4: $1.2M to $1.7M estimate range

So bare minimum we're looking at $5M in revs for IPCI's 2017 revenue which represents a nice increase from the $2M in reported revenue last year...and puts us on track for at least $10M in revs expected in 2018 bare minimum with just the ongoing FocalinXR and SeroquelXR sales from PAR and MNK.